The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TOI The Oncology Institute

Not Yet Opened 12-31 16:00:00 EST

3.56

-0.09

-2.47%

盘后3.66

+0.10+2.81%

19:55 EST

High3.68	Low3.55	Vol1.26M
Open3.66	D1 Closing3.65	Amplitude3.70%
Mkt Cap350.24M	Tradable Cap293.48M	Total Shares98.38M
T/O4.52M	T/O Rate1.52%	Tradable Shares82.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TOI","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":3.56,"timestamp":1767214800000,"preClose":3.65,"halted":0,"volume":1257056,"hourTrading":{"tag":"盘后","latestPrice":3.66,"preClose":3.56,"latestTime":"19:55 EST","volume":19095,"amount":68073.015,"timestamp":1767228904945},"delay":0,"floatShares":82439500,"shares":98381340,"eps":-0.638641,"marketStatus":"Not Yet Opened","change":-0.09,"latestTime":"12-31 16:00:00 EST","open":3.66,"high":3.68,"low":3.545,"amount":4515966.137664,"amplitude":0.036986,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.638641,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767344400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":3.65,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.65,"latestTime":"09:15 EST","volume":1063,"amount":3874.367124,"timestamp":1767190503196},"postHourTrading":{"tag":"盘后","latestPrice":3.66,"preClose":3.56,"latestTime":"19:55 EST","volume":19095,"amount":68073.015,"timestamp":1767228904945},"volumeRatio":1.7333171181060252,"impliedVol":1.0548,"impliedVolPercentile":0.5804},"requestUrl":"/m/hq/s/TOI","defaultTab":"news","newsList":[{"id":"2588778548","title":"the Oncology Institute Announces Resignation of Board Member Gabe Ling","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778548","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778548?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:30","pubTimestamp":1764595800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA5N3BD6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","TOIIW","TOI"],"gpt_icon":0},{"id":"2588778520","title":"Press Release: The Oncology Institute Announces Resignation of Board Member Gabe Ling","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778520","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778520?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:30","pubTimestamp":1764595800,"startTime":"0","endTime":"0","summary":"\"On behalf of the Board of Directors, I want to thank Gabe for his service during an important chapter in The Oncology Institute's development,\" said Anne McGeorge, Chairman of the Board. \"We appreciate the contributions he made throughout his time on the Board and the valuable guidance he provided as the Company navigated its first few years in the public markets. As we continue to strengthen our governance structure, we remain focused on enhancing the Board's capabilities by bringing on strategic and experienced members who will support The Oncology Institute's mission and long-term growth goals.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2586447318","title":"Needham Initiates Coverage on Oncology Institute With Buy Rating, $5 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2586447318","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586447318?lang=en_us&edition=fundamental","pubTime":"2025-11-25 20:59","pubTimestamp":1764075598,"startTime":"0","endTime":"0","summary":"Oncology Institute (TOI) has an average rating of Buy and mean price target of $6.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2586276414","title":"Oncology Institute Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2586276414","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586276414?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:46","pubTimestamp":1764071160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2025 06:46 ET (11:46 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2586342736","title":"Oncology Institute’s Strategic Position and Growth Potential in Value-Based Care Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2586342736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586342736?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:37","pubTimestamp":1764070623,"startTime":"0","endTime":"0","summary":"Oncology Institute (TOI) has received a new Buy rating, initiated by Needham analyst, Matthew Shea. Matthew Shea’s rating is based on the Oncology ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/oncology-institutes-strategic-position-and-growth-potential-in-value-based-care-transition-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/oncology-institutes-strategic-position-and-growth-potential-in-value-based-care-transition-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2585681261","title":"Director Mark L. Pacala Reports Disposal of The Oncology Institute Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585681261","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585681261?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:55","pubTimestamp":1763675742,"startTime":"0","endTime":"0","summary":"Mark L. Pacala, Director, reported a disposal of common shares of The Oncology Institute Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL25q0G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Mark L. Pacala Reports Disposal of The Oncology Institute Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2583683920","title":"Oncology Institute Up Nearly 34%, on Pace for Largest Percent Increase Since June 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2583683920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583683920?lang=en_us&edition=fundamental","pubTime":"2025-11-15 01:11","pubTimestamp":1763140260,"startTime":"0","endTime":"0","summary":"Oncology Institute, Inc.  is currently at $4.12, up $1.05 or 33.93%. --Would be highest close since Nov. 4, 2025, when it closed at $4.24. --On pace for largest percent increase since June 8, 2023, when it rose 36.42%. --Up 1234.95% year-to-date; on pace for best year on record . --Down 63.46% from its all-time closing high of $11.29 on Feb. 19, 2021. --Up 2191.67% from 52 weeks ago , when it closed at $0.18. --Down 13.16% from its 52-week closing high of $4.75 on Oct. 24, 2025. --Traded as high as $4.18; highest intraday level since Nov. 6, 2025, when it hit $4.23. --Up 35.71% at today's intraday high; largest intraday percent increase since May 15, 2025, when it rose as much as 40.51%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2583025865","title":"Oncology Institute Shares Jump 10.6% After Q3 Revenue Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2583025865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583025865?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:39","pubTimestamp":1763131158,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL4N3WQ19U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2583046255","title":"Noble Financial Remains a Buy on Oncology Institute (TOI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583046255","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583046255?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:16","pubTimestamp":1763129804,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Oncology Institute today and set a price target of $8.00. According to TipRanks, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/noble-financial-remains-a-buy-on-oncology-institute-toi-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/noble-financial-remains-a-buy-on-oncology-institute-toi-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOI","NBL","BK4185"],"gpt_icon":0},{"id":"2583576709","title":"Oncology Institute Shares Jump 13.6% Premarket After Q3 Revenue Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2583576709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583576709?lang=en_us&edition=fundamental","pubTime":"2025-11-14 17:15","pubTimestamp":1763111733,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ0P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2583543828","title":"Oncology Institute Shares Climb on Raised FY25 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2583543828","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583543828?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:03","pubTimestamp":1763074980,"startTime":"0","endTime":"0","summary":"Shares of the Oncology Institute rose after the company raised its outlook following a quarter of revenue growth.The stock was up 15% in after-hours trading, at $3.57. Ahead of Thursday's close, the stock had risen nearly tenfold year-to-date.The company, which focuses on cancer care, posted a third-quarter loss of $16.5 million, or 14 cents a share, compared with a loss of $16.1 million, or 18 events a share, a year earlier.Operating revenue rose to $136.6 million, compared with $99.9 million a year earlier. The increase was fueled by a rise in dispensary and patient services revenue, while partially offset by a dip in revenue from clinical trials.Chief Executive Daniel Virnich said Oncology Institute was able to raise its outlook based on growth in its pharmacy business and a strong performance in Florida, as well as its implementation of artificial intelilgence in operations and the patient experience.\"As a leader in oncology value-based care, it is important for us to not only rais","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2583512639","title":"Oncology Institute Q3 Consolidated REV of $136.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512639?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:23","pubTimestamp":1763069002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXE93836:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2583514538","title":"The Oncology Institute Q3 EPS $(0.14) Misses $(0.11) Estimate, Sales $136.564M Beat $122.633M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514538","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514538?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:08","pubTimestamp":1763068125,"startTime":"0","endTime":"0","summary":"The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.11) by 23.89 percent. This is a 22.22 percent increase over losses of $(0.18) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48850133/the-oncology-institute-q3-eps-0-14-misses-0-11-estimate-sales-136-564m-beat-122-633m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"The Oncology Institute Q3 EPS $(0.14) Misses $(0.11) Estimate, Sales $136.564M Beat $122.633M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI"],"gpt_icon":1},{"id":"2583314514","title":"The Oncology Institute Inc. reports Q3 revenue growth and raises 2025 guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2583314514","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583314514?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:07","pubTimestamp":1763068037,"startTime":"0","endTime":"0","summary":"The Oncology Institute Inc. reported a 13% increase in fee-for-service revenue for the third quarter of 2025 compared to the same period in 2024, driven by organic growth in Florida and Oregon. Retail Pharmacy and Dispensary operations generated $75.9 million in revenue and $12.8 million in gross profit during the quarter. The company expects adjusted EBITDA of approximately $0 to $2 million in the fourth quarter of 2025 and projects free cash flow between negative $12 million and negative $21 million for the year. Cash and cash equivalents stood at $27.7 million as of September 30, 2025. Business developments included setting new fill records in the pharmacy segment, signing new in-network MSO providers in Florida, and opening a new pharmacy location in the state.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL5zf5DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","BK4185","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4585","BK4112","TOI","LU2095319765.USD"],"gpt_icon":0},{"id":"2583110475","title":"BRIEF-Oncology Institute Q3 Gross Profit USD 18.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583110475","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583110475?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067949,"startTime":"0","endTime":"0","summary":"BRIEF-Oncology Institute Q3 Gross Profit USD 18.9 Million\n\n\nNov 13 (Reuters) - Oncology Institute Q3 EPS USD -0.14.\n\nQ3 net income USD -16.5 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXD8F4E7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2583511783","title":"Oncology Institute Q3 EPS USD -0.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511783","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511783?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067904,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXD8F4E7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2583146285","title":"Press Release: The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2583146285","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583146285?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067900,"startTime":"0","endTime":"0","summary":"CERRITOS, Calif., Nov. 13, 2025  -- The Oncology Institute, Inc.  , one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance.-- Fee-for-service revenue growth of 13% over Q3 2024, driven by continued. -- Retail Pharmacy and Dispensary set fill records, contributing $75.9. million in revenue and $12.8 million in gross profit in Q3.-- Signed several new in-network MSO providers in the Florida market and. opened our new TOI pharmacy location in Florida.-- Welcomed Kristin England as our new Chief Administrative Officer. All comparisons are to the quarter ended September 30, 2024 unless otherwise noted. -- Consolidated revenue of $136.6 million increased 36.7% from $99.9 million. -- Net loss of $16.5 million compared to net loss of $16.1 million. -- Basic and diluted  earnings per share of $ compared to. -- Adjusted EBITDA of $(3.5) million compared t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2583146835","title":"Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2583146835","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583146835?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:04","pubTimestamp":1763067840,"startTime":"0","endTime":"0","summary":"Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workloadCERRITOS, Calif. and NEW YORK, Nov.  13, 2025  (GLOBE NEWSWIRE) -- Ascertain,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187816/0/en/Ascertain-and-The-Oncology-Institute-Co-Develop-Touchless-AI-Automation-for-Oncology-Administration.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2581044842","title":"Oncology Institute Inc - on Nov 3 Co Determined  Cybersecurity Incident May Delay Fee-for-Service Collections - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581044842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581044842?lang=en_us&edition=fundamental","pubTime":"2025-11-07 07:07","pubTimestamp":1762470445,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2581044840","title":"Oncology Institute Inc - No Evidence of Patient Data Compromise in Incident - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581044840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581044840?lang=en_us&edition=fundamental","pubTime":"2025-11-07 07:07","pubTimestamp":1762470445,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2B6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","TOI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theoncologyinstitute.com","stockEarnings":[{"period":"1week","weight":0.0114},{"period":"1month","weight":0.2109},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.4127},{"period":"1year","weight":10.521},{"period":"ytd","weight":10.521}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.019},{"period":"6month","weight":0.0905},{"period":"1year","weight":0.1635},{"period":"ytd","weight":0.1635}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.360322},{"month":2,"riseRate":0.2,"avgChangeRate":-0.087521},{"month":3,"riseRate":0.4,"avgChangeRate":-0.02005},{"month":4,"riseRate":0.6,"avgChangeRate":0.143821},{"month":5,"riseRate":0.4,"avgChangeRate":-0.057716},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094312},{"month":7,"riseRate":0.833333,"avgChangeRate":0.340043},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.040327},{"month":9,"riseRate":0.5,"avgChangeRate":-0.018468},{"month":10,"riseRate":0.5,"avgChangeRate":0.091691},{"month":11,"riseRate":0,"avgChangeRate":-0.319754},{"month":12,"riseRate":1,"avgChangeRate":0.32933}],"exchange":"NASDAQ","name":"The Oncology Institute","nameEN":"The Oncology Institute"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"The Oncology Institute,TOI,The Oncology Institute股票,The Oncology Institute股票老虎,The Oncology Institute股票老虎国际,The Oncology Institute行情,The Oncology Institute股票行情,The Oncology Institute股价,The Oncology Institute股市,The Oncology Institute股票价格,The Oncology Institute股票交易,The Oncology Institute股票购买,The Oncology Institute股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}